About Saniona

Company Description

Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for patients suffering from rare diseases for which there are a lack of available treatment options.

Year founded

2011

Served area

Worldwide

Headcount

25

Shareholder information

Shares outstanding

62,385,677

IPO

June 15, 2017

Stock exchange(s)

Nasdaq Stockholm

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.